I consistently hear from customers that one of their biggest challenges is how to best manage and learn from the ever-increasing amount of data they collect daily. It’s a significant contributor to why the artificial intelligence (AI) market is forecasted to increase from more than $640 million in 2016 to nearly $37 billion in 2025, with AI workloads growing at an estimated annual rate of 52%1. The rapid growth of data and new technology advancements has made it economically viable to adopt machine learning to disrupt new markets, improve operations, and pave a competitive advantage. Working with our strategic technology partners, we’re able to bring these powerful capabilities to organizations of all sizes and industries in more ways than ever before.At this week’s Supercomputing 2017 conference, we unveiled THREE new solutions that converge our HPC and data analytics expertise along with next generation strategic partner technology and equip organizations to unlock faster, better and deeper data insights. First, what we coin as the ‘bedrock’ of any modern data center, the PowerEdge C4140, an ultra-dense, accelerator optimized server platform designed to handle intensive AI workloads. Coupling the C4140 with our HPC knowhow, we’ve built a new family of Ready Solutions; the Dell EMC Ready Bundles for Machine Learning and Deep Learning enable organizations to realize advancements across a wide array of use cases.When you consider the applications of machine and deep learning in areas like strengthening security with facial recognition, improving health care, and understanding human behavior in retail, the possibilities are endless and exciting!Take, for example, these customer stories:MasterCard leverages artificial intelligence to help protect consumers against credit card fraud. With approximately two million applied rules to automate spend tracking; they handle 160 million transactions per hour and 52 billion per year. Utilizing Dell EMC machine learning technologies, they’ve accelerated the speed with which they can retrieve and validate transaction data, as well as apply new rules to prevent authorized card usage. Of equal importance to stopping unauthorized charges is ensuring that genuine charges are not falsely flagged as fraudulent and prohibited. As their machines become more intelligent, MasterCard is moving closer to a model of complete and proactive oversight, where inaccuracies are prevented before they occur, and customer disruption is minimized.The Texas Advanced Computing Center (TACC) at The University of Texas at Austin is a leading academic center that uses machine learning for critical scientific discoveries, such as identifying brain tumors, developing cures for cancer, and forecasting severe weather conditions, like tornados. In partnership with Dell EMC, Intel, and Seagate, their “Stampede 2” supercomputer is ranked No. 12 on the latest TOP500 list as one of the most powerful computer systems in the world with its more than 18 petaflop performance. These technologies empower them to support thousands of researchers running simulations too complex for their normal desktop environments.As another example, Simon Fraser University’s “Cedar” supercomputer is helping researches in Canada to study DNA bacteria patterns for collaborations with worldwide public health agencies. Unlike the many HPC systems built for narrowly targeted applications, Cedar is designed to run a wide variety of scientific workloads, including those related to personalized medicine, green energy technology, AI and the AI sub-fields of machine learning and deep learning. Simon Fraser’s research findings are leading to better and faster infectious disease control measures, like new vaccination programs, to help keep humankind safe.We’re at the forefront of many incredible breakthroughs in artificial intelligence, stemming from the mastery of machine and deep learning, and only scratching the surface of what’s possible. We told you in October that we’re committed to investments in this space and making AI a reality for all customers. We’re making excellent headway as a company and have already made several exciting announcements, including accelerated computing platforms to support our customers’ unique AI performance needs.Working with the best and brightest minds to better the world is what energizes me and our Dell EMC teams every day to propel our HPC mission towards artificial intelligence-based customer and industry outcomes. Stay tuned for even more announcements and customer successes in this space, as together we advance technology to drive human progress.1 Tractica, Artificial Intelligence Revenue to Reach $36.8 Billion Worldwide by 2025, Aug 2016
Tag: 君悦富侨意境spa 398
Only patients with 10 medical conditions, such as HIV, AIDS, epilepsy, multiple sclerosis and cancer, qualify for the medical marijuana certificates given by physicians registered with the New York State Department of Health. The doctors have to undergo a four-hour training course and pay a $249 fee. As of this week 409 patients have signed up in New York and 302 doctors have registered.Despite the restrictions and the slow implementation of the program, state Assemb. Richard Gottfried (D-Manhattan), who has been sponsoring medical marijuana legislation for almost two decades, remains optimistic.“I would say the glass is three-quarters full, which is pretty good in life,” he said. “Ultimately the law, even as currently written, is going to provide important relief for thousands and thousands of seriously ill patients. I think it could work a whole lot better and serve a lot more patients in need if some of the restrictions the governor insisted on can be changed.”In the current legislative session, the Assemblyman has introduced some amendments to address these concerns.“We’re still going to be working to fill the glass,” he told the Press. “I’ve always believed that on this issue the general public is way ahead of a lot of elected officials.”Advocates for the law hope the health commissioner will exercise his leeway to include at least five more qualifying serious medical conditions and allow doctors to more easily participate in the program. The dispensaries are also on a tight watch to prevent abuse. That intense scrutiny applies to the dispensaries’ suppliers too, noted Gottfried. These producers have to use their own trucks and drivers—not Federal Express, for example—and each truck has to be outfitted like an armored bank truck with its own safe to keep the product locked up. When one driver stops for coffee, another has to remain in the truck at all times.“You would think they’re delivering plutonium,” observed Gottfried.Gottfried disagrees with the health department’s insistence that the list of approved doctors be kept secret.“I don’t think there is any legal justification for doing that,” he said. “The department ought to put it on its website.”Although there’s no publicly available list of certified physicians, Columbia Care maintains its own list it can supply prospective patients. Potential patients, who are battling debilitating illnesses, are also struggling with the restrictions.Before they can receive treatment, patients have to locate a physician who has been approved by the state to issue a prescription. In many cases, their primary care doctor may not even know who they can turn to.“We’ve gotten literally dozens and dozens of calls from patients every day really frustrated and angry that they’re not able to enroll in the program because they can’t find a physician,” said Julie Netherland, a director at the Drug Policy Alliance, which runs the Compassionate Care coalition of patients and caregivers and was involved in lobbying for the bill.“It is a fairly narrow and restrictive program,” she told the Press. “You can see that there are huge areas of the state that are not well served and Long Island is one of them. It’s a big area and only two are slated to open. The very people who qualify for the program are some of the sickest and most disabled folks in New York for whom travel can be really difficult and burdensome.”She said it’s very hard to know how many patients would want to participate in the program, especially considering the limited number of qualifying conditions. One of the five dispensary companies licensed to supply the product in New York told Netherland that they estimated 400,000 to 500,000 patients but “I don’t know how accurate that is.”Patients who qualify have to pay for it out of pocket because medical marijuana is not covered under any health insurance plans. The dispensaries have the option to price the product on a sliding scale in order to subsidize those patients who couldn’t otherwise afford the prescription. The drugs cost between $100-$300.The drug is taken orally, for now. They expect to roll out vapor and pills in the near future.“Somebody who wants to use marijuana for recreational purposes in New York does not need to go through this whole health department process to get access to it,” said Gottried. “You can go to almost any street corner. You don’t have to register your name and address with the state if you’re interested in smoking a joint.”On Long Island, Bloomfield Industries Inc. is opening a dispensary at 2001 Marcus Ave., Suite NI, in Lake Success. Columbia Care runs the dispensary at 1333 East Main St. in Riverhead.“We think this is a wonderful opportunity for patients and physicians to really examine and take advantage of a new form of health care,” Columbia Care CEO Nicholas Vita told the Press inside the facility Friday morning.Vita said about 15 patients have scheduled appointments as of Thursday evening. Over next several weeks it will transition to regular business as opposed to strictly appointment based.“The goal for us is to make sure no one ever comes and leaves empty handed,” Vita said. “If they want medicine, they should be able to get medicine, and that’s something we have the ability to do.”The facility does not have any signs or markings outside indicating it’s a medical marijuana dispensary. Inside, it’s decorated with succulents and retro furniture.Columbia Care has four facilities statewide, which is the max under the law. They’re in Riverhead, Manhattan, Plattsburgh and Rochester.But New Yorkers won’t have the same options patients in other states have.“There are lots of restrictions on the kinds of medical marijuana that are available in New York that don’t apply to other states,” said Netherland, noting that other states permit smokables, edibles, patches and lotions, as well as dozens of different strains. “That’s important because physicians and patients want the flexibility to be able to match a therapeutic strain to a particular set of symptoms. In New York there are only five strains or brands being allowed for each company. So if you go into a dispensary, you’re going to have a fairly limited selection.“We all want to see a well-regulated system,” said Netherland. “The problem is that you have to balance that regulation with patient access.” She thinks the state has tipped the balance too far.“My hope is that as the program rolls out,” Netherland said, “the state will realize that it doesn’t need all the restrictions that it’s put into place and will really change the program in a way that allows the patients to get the medicine they need more easily.”—With Rashed Mian Sign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York [dropcap]L[/dropcap]ittle by little, New York is finally joining 22 other states plus Washington, D.C., in offering medical marijuana to qualified patients at tightly regulated dispensaries that are slowly opening across the Empire State. All told, there will be 20 when the program is fully operational. Two facilities are set to open Friday on Long Island, one in Riverhead and the other at Lake Success.Like Minnesota, New York’s stipulations are very restrictive, permitting the dispensaries to sell the drug only in oils and tinctures—not in smokable or edible form—compared to other states that have legalized medical marijuana.“Our goal is to ensure that New Yorkers have access to the treatment they need through a controlled, regulated process,” State Health Commissioner Dr. Howard Zucker said in a press release when the law passed in 2014 as part of the Compassionate Care Act.